ANVISA registration 82221430025Active

GLYCATED HEMOGLOBIN (HbA1C)

Name: GLYCATED HEMOGLOBIN (HbA1C) — ANVISA registration 82221430025
Creator: ZYBIO INC.
Keywords: GLYCATED HEMOGLOBIN (HbA1C), HEMOGLOBINA GLICADA (HbA1C), Hemoglobina Glicada HbA1c (FIA), 82221430025, Risk Class II, ANVISA registration

ANVISA Registration Number: 82221430025SURE TRADING IMPORTAÇAO E EXPORTAÇAO LTDAZYBIO INC.Risk Class II

Verified

Device names

Technical name: GLYCATED HEMOGLOBIN (HbA1C)
Commercial name: Hemoglobina Glicada HbA1c (FIA)
Risk class: Class II

Registration details

Registration Number: 82221430025
Process Number: 25351324434202267
CNPJ: 38000403000103

Company information

Registration Holder: SURE TRADING IMPORTAÇAO E EXPORTAÇAO LTDA
Manufacturer: ZYBIO INC.
Manufacturing Country: China

Dates and status

Publication Date: Oct 06, 2022
Validity: VIGENTE
Last Updated: 08/18/2026 19:00:00

About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 82221430025 and manufactured by ZYBIO INC.. The registration is held by SURE TRADING IMPORTAÇAO E EXPORTAÇAO LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.